These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3858565)

  • 21. Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis.
    Shimizu M; Saitoh Y; Ohyanagi H; Itoh H
    Arch Pathol Lab Med; 1990 Feb; 114(2):195-200. PubMed ID: 1689141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma].
    Fabris C; Basso D; Meggiato T; Del Favero G; Fogar P; Panozzo MP; Ferrara C; Scalon P; Naccarato R
    Recenti Prog Med; 1991 Mar; 82(3):166-72. PubMed ID: 2047559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of elastase 1 assay as a tumor marker].
    Kimura T; Nawata H
    Nihon Rinsho; 1990 Feb; 48 Suppl():899-902. PubMed ID: 2355631
    [No Abstract]   [Full Text] [Related]  

  • 27. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 7). Usefulness of combination assay].
    Niitsu Y; Kohda K
    Nihon Rinsho; 1986 Aug; 44(8):1843-7. PubMed ID: 3537376
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of discriminant analysis of serum CA 19-9 and elastase 1 in diagnosis of pancreatic carcinoma.
    Yamamura H; Tatsuta M; Ito M; Iishi H; Noguchi S; Okuda S; Yoshida M
    Pancreas; 1989; 4(4):401-5. PubMed ID: 2762270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of CA19-9 with other tumor markers in the diagnosis of cancer of the pancreas.
    Satake K; Takeuchi T
    Pancreas; 1994 Nov; 9(6):720-4. PubMed ID: 7846015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive diagnosis of advanced pancreatic cancer by real-time ultrasonography, carcinoembryonic antigen, and carbohydrate antigen 19-9.
    Wang TH; Lin JT; Chen DS; Sheu JC; Sung JL
    Pancreas; 1986; 1(3):219-23. PubMed ID: 3554223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oncofetal antigen].
    Nishida K; Yoshikawa T; Kondo M
    Nihon Rinsho; 1980; 38(1):152-60. PubMed ID: 6156250
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach.
    Fabris C; Del Favero G; Basso D; Piccoli A; Meggiato T; Angonese C; Plebani M; Leandro G; Burlina A; Naccarato R
    Am J Gastroenterol; 1988 May; 83(5):549-53. PubMed ID: 3163228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor markers in the diagnosis of pancreatic carcinoma].
    Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
    Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
    [No Abstract]   [Full Text] [Related]  

  • 36. The possibility of diagnosing small pancreatic cancer (less than 4.0 cm) by measuring various serum tumor markers. A retrospective study.
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Cancer; 1991 Jul; 68(1):149-52. PubMed ID: 2049735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical localization of CA 19-9 and CEA in pancreatic carcinoma and associated diseases.
    Ichihara T; Nagura H; Nakao A; Sakamoto J; Watanabe T; Takagi H
    Cancer; 1988 Jan; 61(2):324-33. PubMed ID: 3422034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor markers in the upper intestinal tract--stomach and pancreas].
    Pointner R; Conrad F; Schwab G
    Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunologic markers of pancreatic cancer in humans].
    Kulagin PP; Chalov VV
    Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antigens associated with cancer of the pancreas].
    Burtin P
    Bull Cancer; 1990; 77(1):69-73. PubMed ID: 2317577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.